Evidence map›Paper›PMID 37950441›Full record

ArticleBiophysical journal2023

Relationship between antimicrobial peptides-induced cell membrane damage and bactericidal activity.

Md Zahidul Islam, Farzana Hossain, Md Hazrat Ali, Masahito Yamazaki

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Anti-Antibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Md Zahidul IslamNanomaterials Research Division, Research Institute of Electronics, Shizuoka University, Shizuoka, Japan; Department of Biotechnology and Genetic Engineering, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Farzana HossainNanomaterials Research Division, Research Institute of Electronics, Shizuoka University, Shizuoka, Japan.
Md Hazrat AliIntegrated Bioscience Section, Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan.
Masahito YamazakiNanomaterials Research Division, Research Institute of Electronics, Shizuoka University, Shizuoka, Japan; Integrated Bioscience Section, Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan; Department of Physics, Faculty of Science, Shizuoka University, Shizuoka, Japan. Electronic address: yamazaki.masahito@shizuoka.ac.jp.
Shizuoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most antimicrobial peptides (AMPs) act by killing bacterial cells. However, there is little information regarding the required interaction time between AMPs and bacterial cells to exert the bactericidal activity. One of the causes of the bactericidal activity is considered to be cell membrane damage, although little direct evidence is available. Here, we investigated the relationship between AMP-induced cell membrane damage in Escherichia coli and AMP-induced cell death at the single-cell level. Magainin 2, lactoferricin B, and PGLa were selected as the AMPs. First, we examined the interaction time (t) of AMPs with cells required to induce cell death using the single-cell analysis. The fraction of microcolonies containing only a single cell, P

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesCell MembraneCytoplasmMembranesMicrobial Sensitivity TestsOrganic ChemicalsAnti-Bacterial AgentsAntimicrobial PeptidesOrganic ChemicalsSYTOX Green

Identifiers

PMID37950441
PMCPMC10754687
OpenAlexW4388573128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.